4//SEC Filing
ABIOMED INC 4
Accession 0001179110-15-007278
CIK 0000815094operating
Filed
May 6, 8:00 PM ET
Accepted
May 7, 5:51 PM ET
Size
19.1 KB
Accession
0001179110-15-007278
Insider Transaction Report
Form 4
ABIOMED INCABMD
Bowen Robert
Chief Financial Officer
Transactions
- Award
Common Stock, $.01 par value
2015-05-05+18,000→ 84,859 total - Sale
Common Stock, $.01 par value
2015-05-07$71.04/sh−1,549$110,040→ 83,310 total - Sale
Common Stock, $.01 par value
2015-05-07$72.14/sh−573$41,334→ 82,737 total - Sale
Common Stock, $.01 par value
2015-05-07$73.09/sh−250$18,274→ 82,487 total
Holdings
- 100,000
Stock Option (Right to Buy)
Exercise: $15.92From: 2009-12-22Exp: 2018-12-22→ Common Stock (100,000 underlying) - 7,500
Stock Option (right to buy)
Exercise: $10.03From: 2011-06-03Exp: 2020-06-03→ Common Stock (7,500 underlying) - 20,000
Stock Option (right to buy)
Exercise: $22.44From: 2013-05-22Exp: 2023-05-22→ Common Stock (20,000 underlying) - 20,000
Stock Option (Right to Buy)
Exercise: $23.15From: 2014-05-14Exp: 2024-05-14→ Common Stock (20,000 underlying)
Footnotes (7)
- [F1]Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
- [F2]These options become exerciseable in annual 25% increments, commencing on the date set forth in Table II, Column 6.
- [F3]Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on May 14, 2014. One third of these restricted stock units vested on May 5, 2015 (into an equal number of shares of common stock) upon the issuer's achievement of a certain performance milestone with the remaining vesting on the first and second anniversary of the date of the grant.
- [F4]Sale of common stock pursuant to reporting owner's 10b5-1 plan solely for payment of withholding tax liability associated with the vesting of performance-based awards of restricted stock units.
- [F5]This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $70.7400 and $71.6600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F6]This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $71.9000 and $72.7100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- [F7]This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $72.9050 and $73.3400. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Documents
Issuer
ABIOMED INC
CIK 0000815094
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000815094
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 5:51 PM ET
- Size
- 19.1 KB